Steven B. Ketchum, Chief Scientific Officer at AMARIN CORP PLC\UK (AMRN), sold 2,612 shares at $4.40 ($11K) on 2018-01-11, disclosed to the SEC on 2018-01-16.
Scheduled sale ($11k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMRN | SELL | 2021-01-29 | $6.8M | — | Filing → |
| AMRN | SELL | 2019-05-02 | $356K | — | Filing → |
| AMRN | SELL | 2019-04-01 | $381K | — | Filing → |